SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-017863
Filing Date
2024-06-21
Accepted
2024-06-21 18:10:17
Documents
1
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 form4-06212024_060612.html 4  
1 form4-06212024_060612.xml 4 4122
  Complete submission text file 0001415889-24-017863.txt   5777
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Issuer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ZURA BIO INC. 4225 EXECUTIVE SQUARE, SUITE 600 LA JOLLA CA 92037
Business Address
Davis Kim (Reporting) CIK: 0001965590 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40598 | Film No.: 241061626